2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Spondylitis, Ankylosing
1
Somatoform Disorders
1
Prostatic Neoplasms
1
Peripheral Nervous System Diseases
1
Breast Neoplasms
1
Breast Neoplasm Female
1
Bone Neoplasms
1
Interventions
Fulvestrant
3
palbociclib
2
Letrozole
2
Anastrozole
2
venetoclax
1
pyrotinib
1
pertuzumab
1
penpulimab
1
dalpiciclib
1
anlotinib
1
Tretinoin
1
Trastuzumab
1
Ropivacaine
1
Radiosurgery
1
Propofol
1
Patient Reported Outcome Measures
1
Paclitaxel
1
Ondansetron
1
Morphine
1
Induction Chemotherapy
1
Etoricoxib
1
Docetaxel
1
Diagnostic Imaging
1
Carboplatin
1
Capecitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Breast Neoplasm Female
×
Etoricoxib
×
Clear all
NCT03117894
2021-06-04
PECS-2 for Breast Surgery
Umeå University
Phase NA
Completed
200 enrolled